HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,916,265 | -25.1% | 50,164 | -29.2% | 0.01% | -27.3% |
| Q2 2023 | $2,557,147 | -20.5% | 70,894 | -15.8% | 0.01% | -21.4% |
| Q1 2023 | $3,216,515 | +41521.6% | 84,224 | -38.0% | 0.01% | -61.1% |
| Q4 2022 | $7,728 | +43.9% | 135,812 | 0.0% | 0.04% | +38.5% |
| Q3 2022 | $5,370 | -99.9% | 135,812 | +7.8% | 0.03% | 0.0% |
| Q2 2022 | $5,544,000 | +110.6% | 126,009 | +90.9% | 0.03% | +160.0% |
| Q1 2022 | $2,632,000 | +16.9% | 66,009 | +17.9% | 0.01% | +25.0% |
| Q4 2021 | $2,252,000 | -1.2% | 56,009 | 0.0% | 0.01% | -11.1% |
| Q3 2021 | $2,279,000 | -18.5% | 56,009 | -9.1% | 0.01% | -18.2% |
| Q2 2021 | $2,797,000 | -52.6% | 61,587 | -56.5% | 0.01% | -54.2% |
| Q1 2021 | $5,903,000 | +25.6% | 141,587 | +28.7% | 0.02% | +20.0% |
| Q4 2020 | $4,698,000 | – | 110,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |